A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee.

  title={A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee.},
  author={Rodney A. Hughes and Andrew J Carr},
  volume={41 3},
OBJECTIVES A randomized, placebo-controlled, double-blind trial of the relative effectiveness of glucosamine sulphate and placebo in managing pain in osteoarthritis (OA) of the knee. METHODS Eighty patients with OA of the knee were recruited from a rheumatology out-patient clinic and received either glucosamine sulphate 1500 mg daily for 6 months or dummy placebo. The primary outcome measure was patients' global assessment of pain in the affected knee. RESULTS Area under the curve analysis… 

Figures and Tables from this paper

Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.

In patients with knee OA with at least moderate subjective improvement with prior glucosamine use, this study provides no evidence of symptomatic benefit from continued use of glucosamines sulfate.

Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis

The combination of MSM with Glu provides better and more rapid improvement in patients with osteoarthritis and shows better efficacy in reducing pain and swelling and in improving the functional ability of joints than the individual agents.

Short report: ibuprofen versus glucosamine sulfate. Treating osteoarthritis pain.

Evaluating the efficacy and side effect profile of glucosamine sulfate in a 12-week double-blind pilot study aimed to help resolve the ongoing controversy by further evaluating the effects of the drug in osteoarthritis patients.

Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.

Anakinra was well tolerated as a single 50-mg or 150-mg intraarticular injection in patients with OA of the knee, however, anakinRA was not associated with improvements in OA symptoms compared with placebo.

Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta-analysis from the OA trial bank

There is no goodEvidence to support the use of glucosamine for hip or knee OA and an absence of evidence to support specific consideration of glucOSamine for any clinically relevant OA subgroup according to baseline pain severity, BMI, sex, structural abnormalities or presence of inflammation.

A Double-Blind Randomized Placebo Controlled Parallel Group Study Evaluating the Effects of Ibuprofen and Glucosamine Sulfate on Exercise Induced Muscle Soreness

Glucosamine sulphate facilitates Muscle tenderness whereas systemic administration of ibuprofen is not capable of inhibiting experimentally induced muscle tenderness/soreness.

Efficacy of physiotherapy management of knee joint osteoarthritis: a randomised, double blind, placebo controlled trial

The physiotherapy programme tested in this trial was no more effective than regular contact with a therapist at reducing pain and disability.

Glucosamine for pain in osteoarthritis: why do trial results differ?

Heterogeneity among trials of glucosamine is larger than would be expected by chance, and potential explanations include different glucosamines preparations, inadequate allocation concealment, and industry bias.

Glucosamine Long-Term Treatment and the Progression of Knee Osteoarthritis: Systematic Review of Randomized Controlled Trials

The available evidence suggests that glucosamine sulfate may be effective and safe in delaying the progression and improving the symptoms of knee OA.



Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.

Evaluation of benefit of glucosamine and chondroitin preparations for OA symptoms using meta-analysis combined with systematic quality assessment of clinical trials of these preparations in knee and/or hip OA suggests some degree of efficacy appears probable for these preparations.

Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative.

Based on data from clinical trials, two sets of responder criteria have been developed that can categorize an individual's responses to treatment in a clinical trial and require validation in additional datasets.

Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.

Standardized procedures are used to determine in 60 patients with osteoarthritis (OA) of the knee the standard deviation of key outcome measures recommended in current Food and Drug Administration and European League Against Rheumatism guidelines for OA clinical trials.

Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise.

In 2 studies, standardized procedures for conducting outcome measurement based on current Food and Drug Administration and European League Against Rheumatism guidelines for osteoarthritis clinical trials are developed, and the standard deviation for these outcome measures is determined.

The Epidemiology of Chronic Rheumatism

The Hand as a Mfrror of Systemic Disease. By THEODORE J. BERRY. 1963. Pp. 215, 129 figs, bibl. F. A. Davis Company, Philadelphia; Blackwell, Oxford. (£6.) The human hand is a fascinating subject, an

Musculoskeletal Clinical Metrology

The aim of this monograph is to establish a baseline for estimating the sample size requirements for clinical trials in Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis and Fibromyalgia, and to provide a guide for future studies.

The meaning of medications: another look at compliance.

  • P. Conrad
  • Medicine, Psychology
    Social science & medicine
  • 1985